Company: EVGN
Filing Date: 2025-03-27
Form Type: 20-F
Source: 0001178913-25-001092
Chunk: 159

Company: Evogene Ltd.
Filing Date: 2025-03-27
Form: 20-F
Item: Item 4A
Chunk 159
---
64% of our total full-time workforce, of which 36 were employed by Evogene and 39 were
employed by our subsidiaries. In 2024, our employees included individuals with degrees in biology, chemistry, plant genetics, agronomics,
computer and data science and other related fields and 36 of our employees hold a Ph. D. As of March 20, 2025, the total number of employees
in Evogene and its subsidiaries was 106.

The rate of male v. female in our company and our main subsidiaries
as of December 31, 2024, was as follows:

  Company                             
 ──────────────────────────────────────
  Evogene        56      44       66  
  AgPlenus       55      45       11  
  Lavie Bio      47      53       17  
  Biomica        67      33       18  
  Casterra       20      80        5  
  Total          49      51      117  

The rate of male v. female in a managing position (i. e., any such
person that oversees and supervises other employees) in our company and our subsidiaries as of December 31, 2024, was as follows:

  Company        Female      Male  
 ───────────────────────────────────
  Evogene            48        52  
  AgPlenus           80        20  
  Lavie Bio          40        60  
  Biomica            67        33  
  Casterra            0       100  

As of December 31, 2024, all of our employees are based in Israel,
except for two U. S.-based employees. Our two U. S.-based employees are employed by Lavie Bio Inc., a U. S. subsidiary of Lavie Bio Ltd.,
one is based in North Dakota, and one is based in North Carolina. In addition, during 2024, we had on average, approximately 14 hourly
employees who are based in Israel. The following table shows the breakdown of our employees by division/category of activity and by location
as of December 31, 2022, 2023 and 2024, excluding hourly employees:

 ───────────────────────────────────────────────────────────────────────────────────────────────────────────
  Executive management                             6      -         6        5        5        5        5  
  General